Kura Oncology Provides Update on Phase 2 Trial of Tipifarnib in HRAS Mutant Head and Neck Cancer Biotech Investing
Isodiol International Inc. Signs Definitive Agreement to Acquire 100% Of Canadian National Pharma Group Inc. Cannabis Investing News
Scythian Biosciences Corp. Announces Approval for Listing on the Nasdaq Capital Markets Biotech Investing